Peter Nash is Professor of the School of Medicine at Griffith University, Queensland, Australia and Director of the Rheumatology Research Unit Sunshine Coast, Maroochydore, Australia. Professor Nash has chaired the Professional Affairs Committee, the Therapeutics Committee, the National Health and Medical Research Council musculoskeletal panels and served on the Scientific Advisory Committee and ASMPOC of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the international steering committee for the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He is on the editorial board of Annals of the Rheumatic Diseases and RMD Open.

Professor Nash and his group at the Rheumatology Research Unit have been involved in the pivotal registration of clinical trials for all modern targeted biologic therapies and osteoporosis therapies. He has published more than 200 peer-reviewed papers and five book chapters and was recently recognized as Australian rheumatology leader for citations in the top 20 rheumatology journals over the last five years. Special interests include metabolic bone disease and novel therapeutics.